cGAS-STING signalling regulates microglial chemotaxis in genome instability.
Emily J TalbotLisha JoshiPeter ThorntonMahya DezfouliKalliopi TsafouMichael PerkintonSvetlana V KhoronenkovaPublished in: Nucleic acids research (2023)
Defective DNA damage signalling and repair is a hallmark of age-related and genetic neurodegenerative disease. One mechanism implicated in disease progression is DNA damage-driven neuroinflammation, which is largely mediated by tissue-resident immune cells, microglia. Here, we utilise human microglia-like cell models of persistent DNA damage and ATM kinase deficiency to investigate how genome instability shapes microglial function. We demonstrate that upon DNA damage the cytosolic DNA sensing cGAS-STING axis drives chronic inflammation and a robust chemokine response, exemplified by production of CCL5 and CXCL10. Transcriptomic analyses revealed that cell migratory pathways were highly enriched upon IFN-β treatment of human iPSC-derived microglia, indicating that the chemokine response to DNA damage mirrors type I interferon signalling. Furthermore, we find that STING deletion leads to a defect in microglial chemotaxis under basal conditions and upon ATM kinase loss. Overall, this work provides mechanistic insights into cGAS-STING-dependent neuroinflammatory mechanisms and consequences of genome instability in the central nervous system.
Keyphrases
- dna damage
- inflammatory response
- oxidative stress
- neuropathic pain
- single cell
- dna repair
- lipopolysaccharide induced
- lps induced
- endothelial cells
- genome wide
- induced pluripotent stem cells
- cell therapy
- rna seq
- dendritic cells
- traumatic brain injury
- spinal cord
- tyrosine kinase
- spinal cord injury
- stem cells
- gene expression
- single molecule
- combination therapy
- cognitive impairment
- quality improvement
- bone marrow
- brain injury
- copy number